Insomnia: Prevalence, consequences and effective treatment

Medical Journal of Australia

Volumn 199, Issue 8, 2013, Pages S36-S40

  Cunnington, David ^a   Junge, Moira F ^a   Fernando, Antonio T ^b  

^a Melbourne Sleep Disorders Centre   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TEMAZEPAM; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

ARTICLE; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; HEALTH CARE; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; LIGHT EXPOSURE; MINDFULNESS; OUTCOME ASSESSMENT; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; RISK FACTOR; SLEEP AROUSAL DISORDER; SLEEP HYGIENE; SOMNOLENCE; STRESS; ADULT; CHRONIC DISEASE; COGNITIVE THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; HYPERTENSION; MASS SCREENING; MULTIMODALITY CANCER THERAPY; RECURRENT DISEASE; REVIEW; COMPLICATION; DEPRESSIVE DISORDER; SECONDARY PREVENTION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADULT; CHRONIC DISEASE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; HYPNOTICS AND SEDATIVES; MASS SCREENING; MINDFULNESS; RECURRENCE; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SECONDARY PREVENTION;

EID: 84891504434     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10718     Document Type: Article

References (34)

1. Lack L, Miller W, Turner D. A survey of sleeping difficulties in an Australian population. Community Health Stud 1988; 12: 200-207.
2. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J 2008; 38: 24-31.
3. Britt H, Miller G, Charles J, et al. General practice activity in Australia 2009-10. Canberra: Australian Institute of Health and Welfare, 2010. (AIHW Cat. No. GEP 27; General Practice Series No. 27.)
4. Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011; 135: 10-19.
5. Vozoris NT. The relationship between insomnia symptoms and hypertension using United States population-level data. J Hypertens 2013; 31: 663-671.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, Va: American Psychiatric Publishing, 2013.
7. Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician 2009; 38: 283.
8. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987; 10: 541-553.
9. Morin CM, Belanger L, LeBlanc M, et al. The natural history of insomnia: A population-based 3-year longitudinal study. Arch Intern Med 2009; 169: 447.
10. Sivertsen B, Overland S, Bjorvatn B, et al. Does insomnia predict sick leave? The Hordaland health study. J Psychosom Res 2009; 66: 67-74.
11. Arroll B, Fernando A, Falloon K, et al. Development, validation (diagnostic accuracy) and audit of the Auckland Sleep Questionnaire: a new tool for diagnosing causes of sleep disorders in primary care. J Prim Health Care 2011; 3: 107-113.
12. Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011; 34: 601-608.
13. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4: 487-504.
14. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006; 29: 1398-1414.
15. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006; 295: 2851-2858.
16. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008; 31: 489-495.
17. Sivertsen B, Vedaa O, Nordgreen T. The future of insomnia treatment - the challenge of implementation. Sleep 2013; 36: 303-304.
18. Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012; 35: 769-781.
19. Espie CA. “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009; 32: 1549-1558.
20. Bootzin R. A stimulus control treatment for insomnia. Proc Am Psychol Assoc 1972; 7: 395-396.
21. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987; 10: 45-56.
22. Fernando A, Arroll B, Falloon K. A double-blind randomised controlled study of a brief intervention of bedtime restriction for adult patients with primary insomnia. J Prim Health Care 2013; 5: 5-10.
23. Hauri PJ, Esther MS. Insomnia. Mayo Clin Proc 1990; 65: 869-882.
24. Ong JC, Shapiro SL, Manber R. Combining mindfulness meditation with cognitive-behavior therapy for insomnia: a treatment-development study. Behav Ther 2008; 39: 171-182.
25. Ong J, Sholtes D. A mindfulness-based approach to the treatment of insomnia. J Clin Psychol 2010; 66: 1175-1184.
26. Lack LC, Wright HR. Treating chronobiological components of chronic insomnia. Sleep Med 2007; 8: 637-644.
27. Krystal AD, Erman M, Zammit GK, et al; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 2008; 31: 79-90.
28. Roth T, Walsh JK, Krystal A, et al. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 2005; 6: 487-495.
29. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26: 793-799.
30. Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007; 16: 372-380.
31. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9: 25-39.
32. Wiegand MH. Antidepressants for the treatment of insomnia: a suitable approach? Drugs 2008; 68: 2411-2417.
33. Morin CM, Koetter U, Bastien C, et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 2005; 28: 1465-1471.
34. Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med 2006; 119: 1005-1012.